Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DPY19L1 pseudogene 1 (DPY19L1P1) is a human pseudogene, representing a nonfunctional copy of the DPY19L1 gene. Pseudogenes like DPY19L1P1 arise from duplication and subsequent mutation events that prevent them from encoding functional proteins[1]. While DPY19L1P1 is transcribed in some tissues, it does not produce a functional protein and is not implicated in drug targeting or molecular function. However, it can serve as a genomic marker and has been referenced in disease-related transcriptomic studies (e.g., long noncoding RNA profiling)[6]. Distinction: The functional gene DPY19L1 (not DPY19L1P1) encodes a transmembrane protein implicated in protein glycosylation and neural development[2][3][4][5], whereas DPY19L1P1 represents a relic of gene duplication and does not possess similar functional properties. Summary: DPY19L1P1 is a pseudogene, not a receptor, enzyme, or therapeutic target, and should not be considered a valid molecule for drug development or pharmacological profiling. For therapeutic, biological, or molecular classification, "DPY19L1" is appropriate; "DPY19L1P1" is not.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DPY19L1 pseudogene 1 (DPY19L1P1).